Drug intelligence / Profile preview

Clarastill

Development stage
Unknown
Lead developer
Bruschettini
Modality
Small Molecules, Peptides
Administration
Ophthalmic
01

Overview

Clarastill is a sterile, lubricating, and protective ophthalmic solution developed by Bruschettini. It is formulated as a CE class IIa medical device containing carboxymethylcellulose (0.3%), glycerin, and N-acetylcarnosine. Clarastill is indicated for the treatment of alterations of the ocular surface, dry eye syndrome, and ocular irritation or fatigue caused by environmental factors such as wind, smoke, solar radiation, air conditioning, and prolonged screen use. Carboxymethylcellulose and glycerin act as lubricants and humectants to stabilize the tear film and form a protective hydrogel on the corneal surface, while N-acetylcarnosine acts as a prodrug of L-carnosine, providing antioxidant and anti-free radical protection to ocular tissues.

Brand names
ClarastillClarastill Sine
Other names
carboxymethylcellulose + glycerin + N-acetylcarnosinecarboxymethylcellulose / glycerin / N-acetylcarnosine
02

Targets

GLUT1 (Glucose transporter 1)

Beyond the preview

Go deeper on Clarastill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clarastill.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call